Treatment Landscape in New Jersey
New Jersey's 524 licensed treatment facilities serve a state population of 9,290,841. The highest concentrations of facilities are in the northeastern urban corridor — Newark (89 facilities), Jersey City (47), and Paterson (42) — reflecting both population density and historically higher rates of substance use disorders in these communities.
The state recorded an overdose death rate of 33.1 per 100,000 in 2024, slightly above the national average of 32.4.[1] Fentanyl has become the primary driver, involved in roughly three-quarters of drug overdose deaths statewide. In response, New Jersey has expanded MAT access significantly: 198 facilities now offer buprenorphine, methadone, or naltrexone.
Insurance and Medicaid Coverage
New Jersey expanded Medicaid in 2014 under the ACA. NJ FamilyCare covers the full continuum of addiction treatment — medical detox, inpatient residential, outpatient, intensive outpatient, partial hospitalization, and medication-assisted treatment. There is no prior authorization required for emergency detox services.
For privately insured residents, the Mental Health Parity and Addiction Equity Act requires insurers to cover substance abuse treatment at the same level as medical/surgical benefits. Our advisors can verify your specific plan's coverage in minutes — including deductibles, copays, and approved facilities.
State Regulatory Framework
All treatment facilities in New Jersey must hold licensure from the Division of Mental Health and Addiction Services (DMHAS). Verify any facility's license status at nj.gov/humanservices/dmhas. The state requires facilities to maintain specific staff-to-patient ratios, evidence-based treatment protocols, and discharge planning procedures.
Sources & References
- [1] CDC NCHS Drug Poisoning Mortality data. 2024. cdc.gov/nchs
- [2] SAMHSA FindTreatment.gov facility data. Accessed 2026-01-15.
- [3] U.S. Census Bureau, ACS 5-Year Estimates. census.gov
- [4] NSDUH State-Level Prevalence Estimates. samhsa.gov/data